BioMed Research International / 2019 / Article / Tab 1

Clinical Study

Prognostic Nutritional Index and Neutrophil-to-Lymphocyte Ratio Are Respectively Associated with Prognosis of Gastric Cancer with Liver Metatasis Undergoing and without Hepatectomy

Table 1

Characteristics and survival analysis of all patients of GCLM.

PatientsAll GCLMGCLM undergoing hepatectomyGCLM without hepatectomy
Parameter (%) (%) (%)
UnivariateMultivariateUnivariateMultivariateUnivariateMultivariate

Gender0.4090.2580.0780.1110.4770.254
 Male299 (79.9)43 (79.6)256 (80.0)
 Female75 (20.1)11 (20.4)64 (20.0)
Age (57 ± 11)0.0380.4040.3410.7220.1510.489
<58191 (51.1)29 (53.7)162 (50.6)
 ≥58183 (48.9)25 (46.3)158 (49.4)
T stage0.1440.7960.4170.0670.7240.972
 T4b226 (60.4)25 (46.3)201 (63.6)
 Not T4b148 (39.6)29 (53.7)119 (36.4)
N stage0.0270.5080.2340.4810.3890.770
 N0 or N1122 (32.6)18 (33.3)104 (32.5)
 N2 or N3252 (67.4)36 (66.7)216 (67.5)
Number of liver metastases0.0480.5600.8240.4440.5620.433
 Single158 (42.2)38 (70.4)120 (37.5)
 Multiple215 (57.8)16 (29.6)200 (62.5)
Gastrectomy0.0010.059‐‐‐‐‐‐0.0370.096
 Yes159 (42.5)54 (100.0)105 (36.0)
 No215 (57.5)0 (0.0)215 (64.0)
Hepatectomy0.0010.001
 Yes54 (14.4)
 No320 (85.6)
Chemotherapy0.0160.0150.2780.1670.0110.021
 Yes160 (42.8)24 (44.4)136 (42.5)
 No or Unknown214 (57.2)30 (55.6)184 (57.5)
PNI0.0010.1130.0010.0010.3070.871
 <46.8140 (37.4)17 (31.5)123 (38.4)
 ≥46.8234 (62.6)37 (68.5)197 (61.6)
NLR0.0010.0990.1270.7330.0010.001
 <2.86201 (53.7)35 (64.8)166 (49.6)
 ≥2.86173 (46.3)19 (35.2)154 (50.4)

.